Regorafenib in Glioblastoma Recurrence: How to Deal With MR Imaging Treatments Changes
The treatment of recurrent high-grade gliomas remains a major challenge of daily neuro-oncology practice, and imaging findings of new therapies may be challenging. Regorafenib is a multi-kinase inhibitor that has recently been introduced into clinical practice to treat recurrent glioblastoma, bringi...
Main Authors: | Simona Gaudino, Giammaria Marziali, Carolina Giordano, Riccardo Gigli, Giuseppe Varcasia, Francesca Magnani, Silvia Chiesa, Mario Balducci, Alessandro Maria Costantini, Giuseppe Maria Della Pepa, Alessandro Olivi, Rosellina Russo, Cesare Colosimo |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Radiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fradi.2021.790456/full |
Similar Items
-
Clinical and NGS predictors of response to regorafenib in recurrent glioblastoma
by: Silvia Chiesa, et al.
Published: (2022-09-01) -
Osteosarcoma of rib treated with regorafenib: a case report
by: Cemre Uçaryılmaz, et al.
Published: (2021-03-01) -
CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma
by: Ding Ma, et al.
Published: (2024-09-01) -
A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report
by: Simona De Summa, et al.
Published: (2021-11-01) -
Case Report: Should Regorafenib be prescribed as a continuous schedule in gastrointestinal stromal tumors? Three case reports on Regorafenib personalized schedule
by: Maria Susanna Grimaudo, et al.
Published: (2023-05-01)